In brief

Inhaled insulin fails to convince watchdog: The German equivalent of England and Wales's National Institute for Health and Clinical Excellence has pointed out the lack of evidence showing that inhaled insulin (Exubera) has advantages over short acting human insulin or insulin analogues administered subcutaneously. There are indications that inhaled insulin can cause severe hypoglycaemia more often than …